课题基金 / 基金详情

项目摘要

项目成果

STUART A LIPTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant):Emerging evidence suggests the heuristic model that both HIV/AIDS and several forms of drug abuse affect the brain via free radical damage involving the generation of reactive oxygen species (ROS, producing oxidative stress) and reactive nitrogen species (RNS) such as nitric oxide (NO, resulting in nitrosative stress). For example, both HIV- associated neurocognitive disorder (HAND) and methamphetamine appear to produce neuronal damage via oxidative and nitrosative stress (Cadet and Krasnova, 2007). However, the cellular and molecular targets of this free radical stress remain largely unknown. These unknown protein targets are a major challenge for the field and need to be identified in order to develop both Biomarkers of disease and to allow screening for new therapies to prevent corruption of these targets by free radical stress. Here, I propose an innovative approach using newly emerging Mass Spectrometry (MS) techniques to identify the posttranslational modifications (PTMs) of proteins resulting from such nitrosative- and oxidative-induced redox stress and hence identify new protein targets affected by AIDS and drug abuse. Heretofore, it has not been possible to identify the full range of proteins undergoing PTMs due to nitrosative and oxidative stress, but new MS techniques should allow this identification. These newly identified target proteins are expected to serve as Biomarkers of the disease process and also should allow us to direct future therapeutic intervention by discovering new pathogenic pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
  • 批准号:
    10686979
  • 项目类别:
  • 资助金额:
    $45.25万
  • 财政年份:
    2022
  • 负责人:
    STUART A LIPTON
  • 依托单位:
Crosstalk between innate-immunity human microglia and adaptive-immunity Tregs in Alzheimer's disease
  • 批准号:
    10515987
  • 项目类别:
  • 资助金额:
    $44.38万
  • 财政年份:
    2022
  • 负责人:
    STUART A LIPTON
  • 依托单位:
Leadership in AD/ADRD Drug Discovery
  • 批准号:
    10193424
  • 项目类别:
  • 资助金额:
    $106.26万
  • 财政年份:
    2021
  • 负责人:
    STUART A LIPTON
  • 依托单位:
Leadership in AD/ADRD Drug Discovery
  • 批准号:
    10687169
  • 项目类别:
  • 资助金额:
    $108.36万
  • 财政年份:
    2021
  • 负责人:
    STUART A LIPTON
  • 依托单位:
海外基金